Is self-monitoring a cost-effective option for people receiving long-term vitamin K antagonist (Warfarin) therapy? : HERU Policy Brief
Files
There are no files associated with this item.
Publication date
09/2015Author
Metadata
Show full item recordCitation
Scotland , G S 2015 ' Is self-monitoring a cost-effective option for people receiving long-term vitamin K antagonist (Warfarin) therapy? HERU Policy Brief ' University of Aberdeen , Aberdeen , pp. 1-2 .
URI
http://hdl.handle.net/2164/5273https://www.abdn.ac.uk/heru/documents/Policy_Briefs/HERU_PB_Sept_2015.pdf